BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2022
View Archived Issues
BCY-6033: EphA2-targeting BTC with efficacy in NSCLC PDX models
Read More
Enliven Therapeutics describes new Bcr-Abl kinase inhibitors
Read More
Silverback Therapeutics synthesizes TGFR-1 inhibitors and antibody-drug conjugates
Read More
CD38 inhibitors discovered at Napa Therapeutics, Buck Institute
Read More
Kymera Therapeutics presents STAT-degrading PROTACs
Read More
Vertex Pharmaceuticals patents CFTR modulators
Read More
Platform delivers siRNA targeting VEGF intravitreally for diabetic retinopathy
Read More
Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs
Read More
Insilico Medicine nominates preclinical candidate targeting MAT2A for MTAP-deleted cancers
Read More
Betta Pharmaceuticals presents preclinical results for cancer candidates BPI-371153 and BPI-442096
Read More
SPH-5030 demonstrates potent and selective activity in HER2-mutant cancer models
Read More
Orion enters agreement with Jemincare for Nav1.8 blocker for treatment of pain
Read More
Mosaic signs license agreement covering use of cowpea mosaic virus to treat cancer
Read More
Preclinical pipeline progress at Intellia Therapeutics
Read More
Clover reports neutralization findings from preclinical study of bivalent COVID-19 vaccine candidate
Read More
Taking aim at tumor metabolism, while taming toxicity
Read More
